Molndal, Sweden

Ingemar Nilsson

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Astrazeneca Ab. Active years: 2008-2012.

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2008-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ingemar Nilsson: Innovator in Pharmaceutical Compounds

Introduction

Ingemar Nilsson is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. With a total of 2 patents, his work focuses on innovative solutions for medical treatments.

Latest Patents

Ingemar's latest patents include "Compounds 148," which relates to novel pharmaceutically useful compounds that act as competitive inhibitors of trypsin-like serine proteases, especially thrombin. This invention highlights their potential use as medicaments, along with pharmaceutical compositions containing them and synthetic routes for their production. Another significant patent is for "Derivatives of 6-{4-[4-(1H-indole-2-sulphonyl)-piperazin-1-carbonyl-phenyl]}pyridazin-3-one." This invention pertains to heterocyclic derivatives that possess antithrombotic and anticoagulant properties, making them useful in treating humans or animals. The patent also covers processes for preparing these derivatives and their incorporation into pharmaceutical compositions.

Career Highlights

Ingemar Nilsson is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on innovative drug development, contributing to advancements in medical science.

Collaborations

Ingemar has collaborated with notable coworkers, including Yantao Chen and Emma Bratt. Their combined expertise has fostered a productive environment for innovation and research in the pharmaceutical sector.

Conclusion

Ingemar Nilsson's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical treatments through his inventive work. His patents reflect a deep understanding of complex biochemical processes and their applications in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…